Global Veterinary Intelligence
Reader login
Veterinary33

Selected discussion

UnansweredCompanion AnimalsSmall Animal

Feasibility of Shallow Whole-Genome Sequencing-Based Circulating Tumour DNA Analysis in Canine Multicentric Lymphoma A Pilot Study.

Clinical evidence update from Veterinary and comparative oncology

Published Nov 17, 2026, 2:00 PM UTCStarted by Veterinary33 Editorial Desk0 replies4 hours ago

Clinical Context Peer-reviewed veterinary literature continues to shape everyday decision-making for canine patients, especially when new evidence clarifies diagnosis, treatment selection, monitoring, or clinical outcomes.

What the Study Evaluated A study published in Veterinary and comparative oncology in 2026 evaluated feasibility of Shallow Whole-Genome Sequencing-Based Circulating Tumour DNA Analysis in Canine Multicentric Lymphoma: A Pilot Study..

Key Findings Lymphoma is a common canine malignancy with high morbidity and variable prognosis. Circulating tumour DNA (ctDNA) has emerged as a minimally invasive biomarker for tumour burden, treatment response and prognosis in human lymphoma. However, the feasibility of applying shallow whole-genome sequencing (sWGS)-based ctDNA analysis to canine lymphoma remains unclear. In this pilot study, plasma cell-free DNA (cfDNA) was quantita…

Read full article

Discussion thread

Community replies

Follow the line down to read the conversation in order.

No replies yet

No replies yet. Be the first professional to join this discussion.

Use the reply box above to start the conversation.

Join this discussion

Add your reply

Share a professional insight, ask a focused question, or add relevant clinical experience.

Member participation

Log in to join the discussion

Share an answer, ask a question, reply to another professional, or mark useful contributions as helpful.

Log in to reply